Manufacturing

The USFDA approved Plant located at Indrad in Gujarat manufactures both API and Formulations with an annual capacity of 30 million vials.The Plant also hosts a dedicated facility for the global insulin manufacturer, Novo Nordisk. Making Torrent the only Indian contract manufacturer of insulin for Novo Nordisk since the early 90's.

INFRASTRUCTURE

• Total Land: 2,68,800 sq. meters
• Built-up Area: 1,05,757 sq. meters;

CAPACITY

• API Capacity: 45 MT
• Formulations: 5,500 million tablets & capsules, 30 million vials p.a

APPROVALS

FDA (India) USFDA BfArM/RP Oberbayern(Germany) MHRA (UK) TGA (Australia) NDA (Uganda) ANVISA (Brazil) MCC (South Africa) ANMAT (Argentina) BFDA (Taiwan) MCAZ (Zimbabwe) NAFDAC (Nigeria)

MoH (UAE) INVIMA (Columbia) HPFB (Canada) MoH (Tanzania) GCC (Gulf Countries) PPB (Kenya) FDA (Korea) Cofepris (Mexico) MOH (Ukraine) FDA (Philippines) MOH (Combodia)

Indrad : Gujarat

• Total Land: 2,68,800 sq. meters
• API Capacity: 45 MT
• Formulations:
          5,500 Mn tablets & capsules,
          30 Mn vials p.a